From: A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS
GWAS SNP | P-value | Phenotype | PID | LD | PhastCon | Proxy | Maf | FST | Gene | miR | Allele | SVR | S-T | Co | eQTL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
rs10089 | 2.00E-06 | Ileal carcinoids | 21139019 | 1 | 0.6692 | rs10089 | 0.35 | 0.08 | SLC12A2 | hsa-miR-421 | C/T | -0.682 | 8mer | 23 | NA |
rs6504340 | 6.00E-07 | Primary tooth dev | 20195514 | 0.9 | 0.6635 | rs1042822 | 0.18 | NA | HOXB2 | hsa-miR-186 | G/T | -1.341 | 8mer | 62 | NA |
rs328 | 9.00E-23 | HDL cholesterol | 18193044 | 0.93 | 0.685 | rs1059611 | 0.13 | 0.03 | LPL | hsa-miR-136 | T/C | -0.635 | 7mer-m8 | 36 | NA |
rs10503669 | 4.00E-19 | Â | 18193043 | 0.93 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs12678919 | 2.00E-34 | Â | 19060906 | 0.93 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs17482753 | 3.00E-11 | Â | 20031538 | 0.93 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs325 | 8.00E-26 | Â | 20864672 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs6590330 | 2.00E-25 | Systemic lupus erythematosus | 19838193 | 1 | 0.8332 | rs1128334 | 0.06 | 0.44 | ETS1 | hsa-miR-381 | C/T | -1.166 | 7mer-m8 | 33 | F |
rs1128334 | 2.00E-11 | Â | 20169177 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs10941694 | 9.00E-06 | Chronic kidney disease and serum creatinine concentration | 20686651 | 1 | 0.7345 | rs12522910 | 0.14 | NA | HCN1 | hsa-miR-653 | T/C | -1.352 | 8mer | 9 | NA |
rs326 | 5.00E-12 | Triglycerides | 18193046 | 0.96 | 0.6217 | rs13702 | 0.14 | 0.42 | LPL | hsa-miR-410 | T/C | -1.159 | 8mer | 19 | NA |
rs2083637 | 2.00E-10 | Metabolic Syndrome | 20694148 | 0.92 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs10105606 | 4.00E-26 | Hypertriglycerdemia | 20864672 | 0.82 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs1008953 | 1.00E-07 | Psoriasis | 20953189 | 1 | 0.651 | rs2245717 | 0.86 | 0.4 | SYS1 | hsa-miR-150 | T/G | -0.704 | 8mer | 49 | L, F |
rs1443512 | 6.00E-16 | Waist-hip ratio | 20935629 | 0.81 | 0.581 | rs4759058 | 0.78 | Â | HOXC13 | hsa-miR-503 | C/A | -0.755 | 7mer-m8 | 29 | NS |
rs504963 | 2.00E-08 | Crohn's disease | 20570966 | 1 | 0.5968 | rs485073 | 0.63 | NA | FUT2 | hsa-miR-186 | A/G | -1.181 | 7mer-m8 | 63 | NA |
rs281379 | 7.00E-12 | Â | 21102463 | 0.9 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs504963 | 2.00E-08 | Crohn's disease | 20570966 | 1 | 0.5968 | rs603985 | 0.63 | NA | FUT2 | hsa-miR-186 | T/C | -1.181 | 7mer-m8 | 63 | NA |
rs281379 | 7.00E-12 | Â | 21102463 | 0.9 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rs10923931 | 4.00E-08 | Type 2 diabetes | 18372903 | 1 | 0.5784 | rs835576 | 0.07 | Â | NOTCH2 | hsa-miR-218 | T/C | -0.718 | 8mer | 31 | F, L |
rs1295686 | 1.00E-07 | Asthma | 20860503 | 0.96 | 0.581 | rs847 | 0.76 | 0.31 | IL13 | hsa-miR-381 | T/C | -1.159 | 7mer-m8 | 33 | F |
rs20541 | 5.00E-15 | Psoriasis | 19169254 | 0.96 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |